Total Payments
$40,496
2024 Payments
$25,397
Companies
7
Transactions
166
Medicare Patients
141
Medicare Billing
$19,620
Payment Breakdown by Category
Other$20,665 (51.0%)
Consulting$10,828 (26.7%)
Food & Beverage$4,958 (12.2%)
Travel$3,820 (9.4%)
Education$225.41 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20,665 | 8 | 51.0% |
| Consulting Fee | $10,828 | 6 | 26.7% |
| Food and Beverage | $4,958 | 132 | 12.2% |
| Travel and Lodging | $3,820 | 15 | 9.4% |
| Education | $225.41 | 5 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $35,837 | 110 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,938 | 11 | $0 (2024) |
| United Therapeutics Corporation | $1,765 | 28 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $886.96 | 14 | $0 (2024) |
| ABBVIE INC. | $32.36 | 1 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.01 | 1 | $0 (2022) |
| Baxter Healthcare | $16.33 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25,397 | 70 | Actelion Pharmaceuticals US, Inc. ($24,194) |
| 2023 | $12,540 | 69 | Actelion Pharmaceuticals US, Inc. ($11,175) |
| 2022 | $2,145 | 15 | Merck Sharp & Dohme LLC ($1,640) |
| 2021 | $413.66 | 12 | Bayer HealthCare Pharmaceuticals Inc. ($160.69) |
All Payment Transactions
166 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,270.00 | General |
| Category: Cardiology | ||||||
| 12/03/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $133.52 | General |
| Category: Cardiology | ||||||
| 11/25/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Consulting Fee | Cash or cash equivalent | $4,107.50 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Education | In-kind items and services | $18.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/08/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Travel and Lodging | Cash or cash equivalent | $87.00 | General |
| Category: Cardiology | ||||||
| 11/08/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | Cash or cash equivalent | $64.61 | General |
| Category: Cardiology | ||||||
| 11/08/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | Cash or cash equivalent | $25.98 | General |
| Category: Cardiology | ||||||
| 11/08/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | Cash or cash equivalent | $18.00 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Travel and Lodging | In-kind items and services | $383.45 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Travel and Lodging | In-kind items and services | $258.77 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $80.00 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: Cardiology | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/24/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: Cardiology | ||||||
| 10/10/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Travel and Lodging | Cash or cash equivalent | $39.73 | General |
| Category: Cardiology | ||||||
| 10/10/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Cardiology | ||||||
| 10/09/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $119.18 | General |
| Category: Cardiology | ||||||
| 10/09/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $1.99 | General |
| Category: Cardiology | ||||||
| 10/08/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,270.00 | General |
| Category: Cardiology | ||||||
| 10/03/2024 | United Therapeutics Corporation | REMODULIN (Drug) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 60 | 88 | $45,595 | $7,415 |
| 2022 | 2 | 61 | 97 | $54,260 | $9,835 |
| 2021 | 1 | 20 | 22 | $11,770 | $2,369 |
Total Patients
141
Total Services
207
Medicare Billing
$19,620
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 49 | 77 | $41,195 | $6,793 | 16.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 11 | 11 | $4,400 | $622.89 | 14.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 50 | 86 | $46,010 | $8,453 | 18.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 11 | 11 | $8,250 | $1,382 | 16.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 20 | 22 | $11,770 | $2,369 | 20.1% |
About Frances Dy, NP
Frances Dy, NP is a Critical Care Medicine healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2019. The National Provider Identifier (NPI) number assigned to this provider is 1629531686.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Frances Dy, NP has received a total of $40,496 in payments from pharmaceutical and medical device companies, with $25,397 received in 2024. These payments were reported across 166 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($20,665).
As a Medicare-enrolled provider, Dy has provided services to 141 Medicare beneficiaries, totaling 207 services with total Medicare billing of $19,620. Data is available for 3 years (2021–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Acute Care
- Location Los Angeles, CA
- Active Since 04/08/2019
- Last Updated 08/14/2021
- Taxonomy Code 363LC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1629531686
Products in Payments
- UPTRAVI (Drug) $27,354
- OPSUMIT (Drug) $8,443
- Adempas (Drug) $886.96
- REMODULIN (Drug) $594.70
- TYVASO (Drug) $482.07
- WINREVAIR (Biological) $274.54
- AVYCAZ (Drug) $32.36
- ORENITRAM (Drug) $24.68
- LIVTENCITY (Drug) $19.01
- STARLING SYSTEM (Device) $16.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Los Angeles
Igor Barjaktarevic, M.d., M.sc, M.D., M.SC
Critical Care Medicine — Payments: $353,438
Critical Care Medicine $353,438
Dr. Scott Oh, D.o, D.O
Critical Care Medicine — Payments: $273,819
Critical Care Medicine $273,819
David Boldt, M.d, M.D
Critical Care Medicine — Payments: $132,503
Critical Care Medicine $132,503
Tisha Wang, Md, MD
Critical Care Medicine — Payments: $45,715
Critical Care Medicine $45,715
Andrew Wachtel, M.d, M.D
Critical Care Medicine — Payments: $45,694
Critical Care Medicine $45,694
Christopher Newth, Md, MD
Critical Care Medicine — Payments: $29,227
Critical Care Medicine $29,227